In terms of PD-L1, our results show upregulation by IFNγ for most pediatric solid cancers (RMS, brain tumors, EWS, and NB), but no effect on pediatric leukemia and lymphoma cells. This evidence concerns the gene EWSR1 and neuroblastoma.